Sutro Biopharma
STRO
STRO
108 hedge funds and large institutions have $194M invested in Sutro Biopharma in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less call options, than puts
Call options by funds: $3K | Put options by funds: $4K
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
108
Holding in Top 10
–
Calls
$3K
Puts
$4K
Top Buyers
| 1 | +$9.99M | |
| 2 | +$1.93M | |
| 3 | +$1.15M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.12M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$414K |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.43M | |
| 3 | -$1.16M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$995K |
| 5 |
Millennium Management
New York
|
-$917K |